Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
76,178,049
-
Share change
-
-6,312,364
-
Total reported value
-
$1,840,349,819
-
Put/Call ratio
-
41%
-
Price per share
-
$24.15
-
Number of holders
-
365
-
Value change
-
-$233,469,532
-
Number of buys
-
219
-
Number of sells
-
197
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q1 2025
As of 31 Mar 2025,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
365 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,178,049 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, JPMORGAN CHASE & CO, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Pictet Asset Management Holding SA, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and CITADEL ADVISORS LLC.
This page lists
366
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.